2022 Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meeting April 27, 2022 AffaMed Therapeutics Enters into a Licensing Agreement with Hanmi Pharmaceutical to Develop and Commercialize Risuteganib (Luminate®) as a First-In-Class Treatment for Intermediate Dry AMD Patients in Greater China January 3, 2022 View prior press releases
